AIF meets the CHCHD4/Mia40-dependent mitochondrial import pathway.


Journal

Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730

Informations de publication

Date de publication:
01 06 2020
Historique:
received: 27 10 2019
revised: 19 02 2020
accepted: 20 02 2020
pubmed: 28 2 2020
medline: 21 10 2020
entrez: 28 2 2020
Statut: ppublish

Résumé

In the mitochondria of healthy cells, Apoptosis-Inducing factor (AIF) is required for the optimal functioning of the respiratory chain machinery, mitochondrial integrity, cell survival, and proliferation. In all analysed species, it was revealed that the downregulation or depletion of AIF provokes mainly the post-transcriptional loss of respiratory chain Complex I protein subunits. Recent progress in the field has revealed that AIF fulfils its mitochondrial pro-survival function by interacting physically and functionally with CHCHD4, the evolutionarily-conserved human homolog of yeast Mia40. The redox-regulated CHCHD4/Mia40-dependent import machinery operates in the intermembrane space of the mitochondrion and controls the import of a set of nuclear-encoded cysteine-motif carrying protein substrates. In addition to their participation in the biogenesis of specific respiratory chain protein subunits, CHCHD4/Mia40 substrates are also implicated in the control of redox regulation, antioxidant response, translation, lipid homeostasis and mitochondrial ultrastructure and dynamics. Here, we discuss recent insights on the AIF/CHCHD4-dependent protein import pathway and review current data concerning the CHCHD4/Mia40 protein substrates in metazoan. Recent findings and the identification of disease-associated mutations in AIF or in specific CHCHD4/Mia40 substrates have highlighted these proteins as potential therapeutic targets in a variety of human disorders.

Identifiants

pubmed: 32105825
pii: S0925-4439(20)30091-0
doi: 10.1016/j.bbadis.2020.165746
pii:
doi:

Substances chimiques

Apoptosis Inducing Factor 0
CHCHD4 protein, human 0
Disulfides 0
Mitochondrial Membrane Transport Proteins 0
Mitochondrial Precursor Protein Import Complex Proteins 0
Mitochondrial Proteins 0
Electron Transport Complex I EC 7.1.1.2
Cysteine K848JZ4886

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

165746

Subventions

Organisme : Medical Research Council
ID : MC_PC_17190
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R009031/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Camille Reinhardt (C)

Université Paris-Saclay, Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire, 94805 Villejuif, France.

Giuseppe Arena (G)

Université Paris-Saclay, Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire, 94805 Villejuif, France.

Kenza Nedara (K)

Université Paris-Saclay, Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire, 94805 Villejuif, France.

Ruairidh Edwards (R)

Institute of Molecular Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, University Avenue, Glasgow G12 8QQ, Scotland, UK.

Catherine Brenner (C)

Université Paris-Saclay, Inserm, Signalisation et Physiopathologie Cardiovasculaire, 92296 Châtenay-Malabry, France.

Kostas Tokatlidis (K)

Institute of Molecular Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, University Avenue, Glasgow G12 8QQ, Scotland, UK. Electronic address: Kostas.Tokatlidis@glasgow.ac.uk.

Nazanine Modjtahedi (N)

Université Paris-Saclay, Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire, 94805 Villejuif, France. Electronic address: nazanine.modjtahedi@gustaveroussy.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH